Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Angina Pectoris D000787 27 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
pmid:
Kang C et al. Preparation of Sustained Release Tablet with Minimized Usage of Glyceryl Behenate Using Post-Heating Method. 2018 AAPS PharmSciTech pmid:30094721
Fachinetti N et al. Comparative Study of Glyceryl Behenate or Polyoxyethylene 40 Stearate-Based Lipid Carriers for Trans-Resveratrol Delivery: Development, Characterization and Evaluation of the In Vitro Tyrosinase Inhibition. 2018 AAPS PharmSciTech pmid:29404955
Setthacheewakul S et al. Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). 2011 AAPS PharmSciTech pmid:21181511
Scalia S and Mezzena M Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octocrylene: effect on photostability. 2009 AAPS PharmSciTech pmid:19381836
Tran TH et al. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. 2014 AAPS PharmSciTech pmid:25035071
Bhalekar MR et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. 2009 AAPS PharmSciTech pmid:19294517
Rao M et al. Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices. 2009 AAPS PharmSciTech pmid:19333763
Abdelbary G and Fahmy RH Diazepam-loaded solid lipid nanoparticles: design and characterization. 2009 AAPS PharmSciTech pmid:19277870
Refaat A et al. A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets. 2016 Acta Pharm pmid:27749256
Mužíková J et al. Compressibility of tableting materials and properties of tablets with glyceryl behenate. 2015 Acta Pharm pmid:25781708
Gönüllü Ü et al. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. 2015 Acta Pharm pmid:25781700
Patel NV et al. Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine. 2010 Acta Pharm pmid:20228040
Stanisz B et al. Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase. 2010 Jan-Feb Acta Pol Pharm pmid:20210086
Kim HJ et al. Sustained-release formulation of sarpogrelate hydrochloride. 2015 Arch. Pharm. Res. pmid:24895147
Negi JS et al. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique. 2014 Arch. Pharm. Res. pmid:23695866
Jeong SH and Park K Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets. 2010 Arch. Pharm. Res. pmid:20191352
Pradhan M et al. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders. 2016 Artif Cells Nanomed Biotechnol pmid:25229831
Montana G et al. Employment of cationic solid-lipid nanoparticles as RNA carriers. 2007 Mar-Apr Bioconjug. Chem. pmid:17253655
Pivette P et al. Polymorphism of glyceryl behenates: from the individual compounds to the pharmaceutical excipient. 2014 Chem. Phys. Lipids pmid:25062895
Butani D et al. Topical Amphotericin B solid lipid nanoparticles: Design and development. 2016 Colloids Surf B Biointerfaces pmid:26700229
Vithani K et al. Sustained release solid lipid matrices processed by hot-melt extrusion (HME). 2013 Colloids Surf B Biointerfaces pmid:23759381
Moazeni M et al. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. 2016 Colloids Surf B Biointerfaces pmid:26974361
Patere SN et al. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. 2013 Curr Drug Deliv pmid:23607649
Acevedo-Morantes CY et al. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells. 2013 Drug Deliv pmid:24024505
Barakat NS et al. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. 2009 Drug Deliv pmid:19555310
Hosny KM et al. Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia. 2015 Drug Des Devel Ther pmid:25609917
McGinity M et al. Implant compositions for the unidirectional delivery of drugs to the brain. 2017 Drug Dev Ind Pharm pmid:28422529
Wong PC et al. A study on the solid state characteristics of spray-congealed glyceryl dibehenate solid lipid microparticles containing ibuprofen. 2016 Drug Dev Ind Pharm pmid:26079425
Rosiaux Y et al. Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO. 2015 Drug Dev Ind Pharm pmid:25652358
Gu X et al. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. 2004 Drug Dev Ind Pharm pmid:15595567
Iloañusi NO and Schwartz JB The effect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization. 1998 Drug Dev Ind Pharm pmid:15605595
Roberts M et al. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. 2012 Drug Dev Ind Pharm pmid:22149472
Stanisz B et al. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. 2013 Drug Dev Ind Pharm pmid:22348774
Yang R et al. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. 2011 Drug Dev Ind Pharm pmid:20578879
Punyamurthula NS et al. Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol. 2016 Drug Dev Ind Pharm pmid:26585693
Scalia S and Mezzena M Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. 2009 Drug Dev Ind Pharm pmid:18785040
Zhang YE and Schwartz JB Melt granulation and heat treatment for wax matrix-controlled drug release. 2003 Drug Dev Ind Pharm pmid:12648009
Mirghani A et al. Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate. 2000 Drug Dev Ind Pharm pmid:10872101
Faham A et al. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. 2000 Drug Dev Ind Pharm pmid:10697753
Hariharan M et al. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. 2004 Drug Dev Ind Pharm pmid:15285329
Shah M et al. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. 2011 Drug Dev Ind Pharm pmid:21128704
Hamza Yel-S and Aburahma MH Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. 2010 Drug Dev Ind Pharm pmid:19722915
UÄŸurlu T et al. Effects of lubricants on binary direct compression mixtures. 2010 Drug Discov Ther pmid:22491169
Thakkar H et al. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. 2007 Drugs R D pmid:17767393
Pedersen N et al. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. 2006 Eur J Pharm Biopharm pmid:16290122
Jedinger N et al. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids. 2015 Eur J Pharm Biopharm pmid:25733499
Jenning V et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. 2000 Eur J Pharm Biopharm pmid:10799811
Ghimire M et al. Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy. 2011 Eur J Pharm Biopharm pmid:20971189
Ghimire M et al. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. 2007 Eur J Pharm Biopharm pmid:17498934